RxDoctor Payments Data

Christian Blackwell, NP

Nurse Practitioner · Fort Walton Beach, FLNPI 1922494657

Payments from drug & device makers

$1,512in general payments, 2019–2025

Across 66 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$338
  • AstraZeneca$304
  • Novo Nordisk$261
  • Johnson & Johnson$189
  • Amgen$168
  • Boehringer Ingelheim$59
  • plus $193 from 7 others

What the payments were for

  • Food & beverage$1,512100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,512 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$13,556
Medicare patients
80
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$26,550
MounjaroTirzepatide20$26,277
EliquisApixaban17$23,140
JanuviaSitagliptin Phosphate11$14,291
Albuterol Sulfate HfaAlbuterol Sulfate71$2,183
Atorvastatin Calcium88$531
Losartan Potassium64$477
Lisinopril67$474
Levothyroxine Sodium52$453
Metoprolol Succinate52$447
Gabapentin17$427
Omeprazole17$373
Tizanidine Hcl13$315
Fluticasone Propionate19$298
Ibuprofen17$285

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$338$26,55019 claims
Lilly USA, LLCMounjaro$46$26,27720 claims
PfizerEliquis$37$23,14017 claims
MerckJanuvia$12$14,29111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Fort Walton Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →